EBS
Emergent Biosolutions Inc.
A specialty biopharmaceutical company that makes medicines to protect against biological threats and opioid overdoses. Its best-known products include BioThrax, a vaccine against anthrax, and NARCAN, a nasal spray that reverses opioid overdoses and became the first naloxone product sold over the counter without a prescription. Founded in 1998 as BioPort, the company took over Michigan's anthrax vaccine facilities and later renamed itself Emergent BioSolutions, a nod to its role in helping people emerge from public health emergencies.
CUSIP: 29089Q105HealthcareUS1 holder
Total Value
$2.82M
Total Shares
122.7K
Net Share Change
+63.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
